Completed NA INTERVENTIONAL 2-arm NCT02278692

Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy (VitK-CUA)

Sponsor: American Heart Association

Conditions Calcific Uremic Arteriolopathy Calciphylaxis

Updated 8 times since 2017 Last updated: Sep 15, 2019 Started: Mar 31, 2015 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Calcific Uremic Arteriolopathy and Calciphylaxis and is currently completed. American Heart Association leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Jun 2025 — Present [monthly]

Completed NA
Sep 2024 — Jun 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Oct 2019 [monthly]

Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Heart Association
Harvard University
Massachusetts General Hospital
National Kidney Foundation, United States

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States